{"schemaVersion":1,"records":[{"id":"dgfm-poison-2026","title":"DGfM · Giftpilze mit Syndromen, nach Taxa","url":"https://www.dgfm-ev.de/files/dokumente/PSV/2026-06-01_giftpilze-nach-taxa.pdf","year":null,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Arteinträge Inocybe geophylla und Pseudosperma rimosa [Listenschreibweise]: Muskarin-Syndrom; Stand 01.05.2026.","accessedAt":"2026-10-03","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"lepiota-amatoxins-2022","title":"Occurrence and chemotaxonomical analysis of amatoxins in Lepiota spp.","url":"https://pubmed.ncbi.nlm.nih.gov/34965486/","year":2022,"doi":"10.1016/j.phytochem.2021.113069","readingStatus":"abstract_read","readingScope":"Abstract gelesen: 48 Kollektionen, 16 Arten, UHPLC-QTOF-MS/MS. Keine Volltextauswertung; keine Übertragung auf jede Population.","accessedAt":"2026-10-03","catalogId":"lepiota-amatoxins-2022","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"bfr-muscimol-2025","title":"Fliegenpilzgift: gesundheitliche Risiken muscimolhaltiger „Fruchtgummis“","url":"https://www.bfr.bund.de/mitteilung/fliegenpilzgift-gesundheitliche-risiken-muscimolhaltiger-fruchtgummis-kinder-sind-besonders-gefaehrdet/","year":2025,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Abschnitte zu Wirkstoffen und Vergiftungen; keine Übertragung von Produktmengen auf Fruchtkörper","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"fda-amanita-2024","title":"Scientific Memorandum: Amanita muscaria","url":"https://www.fda.gov/media/184512/download","year":2024,"doi":null,"readingStatus":"selected_sections_read","readingScope":"S. 4, 6 und 9: traditionelle Nutzung, Verarbeitung und experimentelle Anwendungen; Sicherheitsbewertung für Lebensmittel, keine klinische Wirksamkeitsstudie","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tsunoda-processing-1993","title":"Change in Ibotenic Acid and Muscimol Contents in Amanita muscaria during Drying, Storing or Cooking","url":"https://www.jstage.jst.go.jp/article/shokueishi1960/34/2/34_2_153/_article","year":1993,"doi":"10.3358/shokueishi.34.153","readingStatus":"abstract_read","readingScope":"Englisches Abstract gelesen; J. Food Hyg. Soc. Japan 34:153–160; DOI 10.3358/shokueishi.34.153","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tsunoda-variation-1993","title":"Changes in Concentration of Ibotenic Acid and Muscimol in the Fruit Body of Amanita muscaria during the Reproduction Stage","url":"https://www.jstage.jst.go.jp/article/shokueishi1960/34/1/34_1_18/_article","year":1993,"doi":"10.3358/shokueishi.34.18","readingStatus":"abstract_read","readingScope":"Englisches Abstract gelesen; 34:18–24; DOI 10.3358/shokueishi.34.18","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ordak-2023","title":"Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria","url":"https://pubmed.ncbi.nlm.nih.gov/37112610/","year":2023,"doi":"10.3390/toxics11040383","readingStatus":"selected_sections_read","readingScope":"Abstract und indexierte Ergebnispassagen: Auswertung von Social-Media-Berichten; Toxics 11(4):383; DOI 10.3390/toxics11040383","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"heiss-2019","title":"Convection-Enhanced Delivery of Muscimol in Patients with Drug-Resistant Epilepsy","url":"https://pubmed.ncbi.nlm.nih.gov/30407567/","year":2019,"doi":"10.1093/neuros/nyy480","readingStatus":"selected_sections_read","readingScope":"Abstract und indexierte Methoden-/Ergebnispassagen: Phase 1, drei Erwachsene, direkte intrazerebrale Infusion; Neurosurgery 85:E4–E15; DOI 10.1093/neuros/nyy480","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"lurie-2009","title":"Mushroom poisoning from species of genus Inocybe: a case series with exact species identification","url":"https://pubmed.ncbi.nlm.nih.gov/19566380/","year":2009,"doi":"10.1080/15563650903008448","readingStatus":"abstract_read","readingScope":"Abstract gelesen; 14 behandelte Fälle; Clin. Toxicol. 47:562–565; DOI 10.1080/15563650903008448","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"bushnell-2002","title":"Structural basis of transcription: α-amanitin–RNA polymerase II cocrystal at 2.8 Å resolution","url":"https://pubmed.ncbi.nlm.nih.gov/11805306/","year":2002,"doi":"10.1073/pnas.251664698","readingStatus":"abstract_read","readingScope":"Indexiertes Abstract zur Röntgenstruktur des Hefe-Enzyms; PNAS 99:1218–1222; DOI 10.1073/pnas.251664698","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"orellanine-cohort-2017","title":"Long-term clinical outcome for patients poisoned by the fungal nephrotoxin orellanine","url":"https://link.springer.com/article/10.1186/s12882-017-0533-6","year":2017,"doi":"10.1186/s12882-017-0533-6","readingStatus":"selected_sections_read","readingScope":"Abstract sowie Abschnitte Background und Results: 28 eingeschlossene Fälle; DOI 10.1186/s12882-017-0533-6","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"vohra-2024","title":"A 19-year longitudinal assessment of gyromitrin-containing (Gyromitra spp.) mushroom poisonings in Michigan","url":"https://doi.org/10.1016/j.toxicon.2024.107825","year":2024,"doi":"10.1016/j.toxicon.2024.107825","readingStatus":"selected_sections_read","readingScope":"Autoren-PDF, S. 1–2: Abstract, Einleitung und Methoden; 118 Meldungen, davon 83 symptomatisch; Toxicon 247:107825","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"coprin-enzyme-1977","title":"Effects on rat liver acetaldehyde dehydrogenases in vitro and in vivo by coprine","url":"https://pubmed.ncbi.nlm.nih.gov/577107/","year":1977,"doi":null,"readingStatus":"abstract_read","readingScope":"Indexiertes Abstract: Coprin und 1-Aminocyclopropanol, Enzymversuche und Rattenmodell; kein klinischer Therapienachweis","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"coprin-human-cells-1988","title":"Effects of disulfiram, cyanamide and 1-aminocyclopropanol on aldehyde dehydrogenase activity in human erythrocytes and leukocytes","url":"https://pubmed.ncbi.nlm.nih.gov/2848231/","year":1988,"doi":null,"readingStatus":"abstract_read","readingScope":"Indexiertes Abstract zu menschlichen Blutzellen; Zellversuch, keine Anwendung am Menschen","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"dgfm-syndromes","title":"Vergiftungssyndrome","url":"https://www.dgfm-ev.de/de/beschreibung-symptome-und-karenzzeiten","year":2023,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Abschnitte Amatoxin, Gyromitrin, Orellanus, Muscarin, Pantherina, Coprinus und Paxillus; Artzuordnung und zeitliche Einordnung","accessedAt":"2026-10-01","catalogId":"dgfm-syndromes","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"helsenorge-poisons","title":"Poisonous mushrooms in Norway","url":"https://www.helsenorge.no/en/poison-information/poisonous-mushrooms/","year":null,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Abschnitte Hepatotoxic mushrooms und Nephrotoxic mushrooms; klinische Einordnung","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"fn14-clitocybe-phyllophila","title":"First Nature · clitocybe phyllophila","url":"https://www.first-nature.com/fungi/clitocybe-phyllophila.php","year":null,"doi":null,"readingStatus":"page_read","readingScope":"Artbeschreibung mit Bestimmungsmerkmalen, Mikroskopie, Ökologie und Artvergleichen gelesen. Britische Saison nicht als gesamteuropäischer Kalender verwendet.","accessedAt":"2026-10-04","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-raison-2023","title":"Single-Dose Psilocybin Treatment for Major Depressive Disorder","url":"https://doi.org/10.1001/jama.2023.14530","year":2023,"doi":"10.1001/jama.2023.14530","readingStatus":"selected_sections_read","readingScope":"Abstract, Methoden, Ergebnisse und Einschränkungen der korrigierten Verlagsfassung gelesen; n=104.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-carhart-2021","title":"Trial of Psilocybin versus Escitalopram for Depression","url":"https://pubmed.ncbi.nlm.nih.gov/33852780/","year":2021,"doi":null,"readingStatus":"abstract_read","readingScope":"PubMed-Abstract gelesen; primärer Endpunkt nach sechs Wochen, n=59. Kein Volltextreview.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-goodwin-2022","title":"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression","url":"https://doi.org/10.1056/NEJMoa2206443","year":2022,"doi":"10.1056/NEJMoa2206443","readingStatus":"abstract_read","readingScope":"Abstract im Publikationsarchiv Stanford Health Care gelesen (861/861298.html); n=233. Kein Volltextreview.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-episode-2026","title":"Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial","url":"https://doi.org/10.1001/jamapsychiatry.2026.0132","year":2026,"doi":"10.1001/jamapsychiatry.2026.0132","readingStatus":"selected_sections_read","readingScope":"Verlagsfassung: Abstract, Methoden und Ergebnisse gelesen. 144 randomisiert; 142 in der Intention-to-treat-Auswertung; primärer Endpunkt und schwerwiegende Reaktionen.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-yngwe-2026","title":"Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial","url":"https://doi.org/10.1001/jamanetworkopen.2026.12589","year":2026,"doi":"10.1001/jamanetworkopen.2026.12589","readingStatus":"selected_sections_read","readingScope":"Verlagsabstract und Ergebnispassagen gelesen; n=35, primär Tag 8, weitere Nachbeobachtung bis Tag 365.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-rucker-2026","title":"Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial","url":"https://doi.org/10.1038/s41591-026-04541-0","year":2026,"doi":"10.1038/s41591-026-04541-0","readingStatus":"abstract_read","readingScope":"Veröffentlichtes Abstract im institutionellen Archiv King’s College London gelesen. Machbarkeitsstudie, n=60; klinische Effektschätzung ist nicht der primäre Machbarkeitsendpunkt.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-bogenschutz-2022","title":"Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder","url":"https://doi.org/10.1001/jamapsychiatry.2022.2096","year":2022,"doi":"10.1001/jamapsychiatry.2022.2096","readingStatus":"abstract_read","readingScope":"PubMed-Abstract gelesen; 95 randomisiert, 93 behandelt; Anteil schwerer Trinktage über 32 Wochen.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-rieser-2025","title":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","url":"https://doi.org/10.1016/j.eclinm.2025.103149","year":2025,"doi":"10.1016/j.eclinm.2025.103149","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC (PMID 40144690) gelesen; 37 Teilnehmende in der Vierwochen-Auswertung nach Entzugsbehandlung.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-cavanna-2022","title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","url":"https://doi.org/10.1038/s41398-022-02039-0","year":2022,"doi":"10.1038/s41398-022-02039-0","readingStatus":"abstract_read","readingScope":"Veröffentlichtes Abstract im institutionellen Archiv Tilburg University gelesen; n=34, akute und kurzfristige Effekte. Kein Volltextreview.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-madsen-2019","title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","url":"https://doi.org/10.1038/s41386-019-0324-9","year":2019,"doi":"10.1038/s41386-019-0324-9","readingStatus":"selected_sections_read","readingScope":"Abstract und Einleitung gelesen; PET-Studie an acht gesunden Freiwilligen. Korrektur veröffentlicht unter DOI 10.1038/s41386-019-0360-5; keine einzelnen Bindungsprozentwerte übernommen.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-holze-2023","title":"Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants","url":"https://doi.org/10.1002/cpt.2821","year":2023,"doi":"10.1002/cpt.2821","readingStatus":"selected_sections_read","readingScope":"Verlagsfassung: Einleitung, Methoden und Ergebnisse einschließlich Tabelle 1 gelesen; Daten zweier Studien an gesunden Personen, keine Wirksamkeitsstudie bei Depression.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"ps-gotvaldova-2022","title":"Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids","url":"https://doi.org/10.3390/ijms232214068","year":2022,"doi":"10.3390/ijms232214068","readingStatus":"selected_sections_read","readingScope":"Tabelle 1 und Abschnitte 2.1–2.3 sowie Diskussion: analytischer Nachweis und Variation. Keine Übertragung von Studienpräparaten auf Fruchtkörper.","accessedAt":"2026-10-05","catalogId":"gotvaldova-tryptamines-2022","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-kaya","title":"Amatoxin and phallotoxin concentration in Amanita phalloides spores and tissues","url":"https://pubmed.ncbi.nlm.nih.gov/23719849/","year":2015,"doi":"10.1177/0748233713491809","readingStatus":"abstract_read","readingScope":"Abstract gelesen; sechs Fruchtkörper, eine türkische Fundstelle, HPLC; online 2013, Heft 2015.","accessedAt":"2026-10-10","catalogId":"tx219-kaya","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-phalloidin","title":"Toxicokinetics and tissue distribution of phalloidin in mice","url":"https://pubmed.ncbi.nlm.nih.gov/37598851/","year":2023,"doi":"10.1016/j.fct.2023.113994","readingStatus":"abstract_read","readingScope":"Abstract gelesen; Mausmodell und Caco-2-Zellen, keine klinische Expositionsstudie (2023).","accessedAt":"2026-10-10","catalogId":"tx219-phalloidin","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-transport","title":"Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins","url":"https://pubmed.ncbi.nlm.nih.gov/14530907/","year":2003,"doi":"10.1007/s00210-003-0814-4","readingStatus":"abstract_read","readingScope":"Abstract gelesen; transfizierte HEK293-Zellen mit menschlichen Transportern, keine Patientenbehandlung (2003).","accessedAt":"2026-10-10","catalogId":"tx219-transport","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-illudin","title":"A Chemical Proteomic Analysis of Illudin-Interacting Proteins","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6900183/","year":2019,"doi":"10.1002/chem.201902919","readingStatus":"selected_sections_read","readingScope":"Indexierte Einleitung und Zusammenfassung zu Zytotoxizität und Selektivitätsgrenzen gelesen (2019); keine klinische Wirksamkeitsbewertung.","accessedAt":"2026-10-10","catalogId":"tx219-illudin","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-acro-analysis","title":"Mass spectrometric determination of acromelic acid A from a new poisonous mushroom: Clitocybe amoenolens","url":"https://pubmed.ncbi.nlm.nih.gov/15560485/","year":2004,"doi":"10.1016/j.chroma.2004.08.133","readingStatus":"abstract_read","readingScope":"Abstract über Europe PMC gelesen; LC-MS-Nachweis in getrocknetem Pilzmaterial (2004).","accessedAt":"2026-10-10","catalogId":"tx219-acro-analysis","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-acro-cases","title":"Erythromelalgia and mushroom poisoning","url":"https://pubmed.ncbi.nlm.nih.gov/11527236/","year":2001,"doi":"10.1081/clt-100105162","readingStatus":"abstract_read","readingScope":"Abstract über Europe PMC gelesen; sieben europäische Fälle, Artzuordnung als mögliche Ursache formuliert (2001).","accessedAt":"2026-10-10","catalogId":"tx219-acro-cases","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-acro-model","title":"Acute and late effects on induction of allodynia by acromelic acid","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1575046/","year":2004,"doi":"10.1038/sj.bjp.0705834","readingStatus":"selected_sections_read","readingScope":"Abstract, Einleitung und Versuchsansatz gelesen; intrathekale Gabe im Mausmodell, verschiedene Wirkungen der Isomere (2004).","accessedAt":"2026-10-10","catalogId":"tx219-acro-model","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-acro-glia","title":"Comparison of mechanisms of allodynia induced by acromelic acid A between early and late phases","url":"https://pubmed.ncbi.nlm.nih.gov/25861935/","year":2015,"doi":"10.1016/j.ejphar.2015.03.075","readingStatus":"abstract_read","readingScope":"Abstract gelesen; frühe und späte Allodynie im Mausmodell (2015).","accessedAt":"2026-10-10","catalogId":"tx219-acro-glia","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-ustalic-original","title":"Ustalic acid as a toxin and related compounds from the mushroom Tricholoma ustale","url":"https://pubmed.ncbi.nlm.nih.gov/12125567/","year":2002,"doi":"10.1039/b202607d","readingStatus":"abstract_read","readingScope":"Abstract gelesen; Isolierung, Spektraldaten und Synthese (2002). Historisches japanisches Artkonzept beachten.","accessedAt":"2026-10-10","catalogId":"tx219-ustalic-original","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-ustalic-food","title":"Quantitative analysis of the Tricholoma ustale-derived toxin, ustalic acid, in mushroom and food samples by LC-MS/MS","url":"https://pubmed.ncbi.nlm.nih.gov/33147547/","year":2020,"doi":"10.1016/j.forsciint.2020.110554","readingStatus":"abstract_read","readingScope":"Abstract gelesen; Methodik und Anwendung auf Mahlzeitreste eines Vergiftungsfalls; historische Artbezeichnung (2020).","accessedAt":"2026-10-10","catalogId":"tx219-ustalic-food","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx219-ustalic-2025","title":"Genomic and Metabolite Analysis-Driven Revision of Basidiomycete Natural Product Biosynthetic Pathway","url":"https://www.jstage.jst.go.jp/article/cpb/73/12/73_c25-00594/_html/-char/en","year":2025,"doi":"10.1248/cpb.c25-00594","readingStatus":"selected_sections_read","readingScope":"Abstract, Einleitung und Ergebnisse 3.1–3.4 gelesen; Kulturen von T. stans und T. albobrunneum, uta-Gencluster; Taxonbezug T. kakishimeji (2025).","accessedAt":"2026-10-10","catalogId":"tx219-ustalic-2025","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"tx220-bolesatin-structure","title":"Characterization of bolesatine … and its effects on kidney cells (1991)","url":"https://pubmed.ncbi.nlm.nih.gov/1707561/","year":1991,"doi":null,"readingStatus":"abstract_read","readingScope":"Abstract gelesen: einkettiges Glykoprotein, relative Molekülmasse 63.000 ± 3.000, intramolekulare Disulfidbrücke; kein vollständiges Strukturmodell.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-bolesatin-sequence","title":"Properties of bolesatine … Amino-terminal sequence determination (1992)","url":"https://pubmed.ncbi.nlm.nih.gov/1471233/","year":1992,"doi":null,"readingStatus":"abstract_read","readingScope":"Abstract gelesen: N-terminaler Sequenzausschnitt und Charakterisierung; keine vollständige Aminosäuresequenz oder räumliche Struktur daraus ableitbar.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-polyporic","title":"Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid … in rats and humans (1998)","url":"https://pubmed.ncbi.nlm.nih.gov/9879809/","year":1998,"doi":null,"readingStatus":"abstract_read","readingScope":"Indexierte Abstractpassagen: Enzymhemmung und Zellversuche; kein vollständiger Volltextreview.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-hapalopilus","title":"Tender Nesting Polypore (Hapalopilus rutilans) poisoning: report of two cases (2013)","url":"https://pubmed.ncbi.nlm.nih.gov/23937526/","year":2013,"doi":null,"readingStatus":"abstract_read","readingScope":"Indexiertes Abstract: zwei Fälle; Polyporsäure als wahrscheinlich wirksamer Giftstoff bezeichnet.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-cycloprop","title":"Identification of the toxic trigger in mushroom poisoning (2009)","url":"https://pubmed.ncbi.nlm.nih.gov/19465932/","year":2009,"doi":"10.1038/nchembio.179","readingStatus":"abstract_read","readingScope":"Abstract gelesen; Isolation aus Russula subnigricans, Kreatinphosphokinase im Mausmodell; DOI 10.1038/nchembio.179.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-russula","title":"A Case of Mushroom Poisoning with Russula subnigricans: Development of Rhabdomyolysis, Acute Kidney Injury, Cardiogenic Shock, and Death (2016)","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4901012/","year":2016,"doi":null,"readingStatus":"abstract_read","readingScope":"Indexierte Zusammenfassung des Fallberichts gelesen; kein Einzelnachweis des isolierten Stoffes beim Patienten.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-satratoxin-isolation","title":"Toxic principles of a poisonous mushroom Podostroma cornu-damae (2001)","url":"https://doi.org/10.1016/S0040-4020(01)00824-9","year":2001,"doi":"10.1016/S0040-4020(01)00824-9","readingStatus":"abstract_read","readingScope":"Autorenabstract über Keio University gelesen: Kultur und Fruchtkörper getrennt; Satratoxin H aus beiden isoliert.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-satratoxin-case","title":"Identification of trichothecene-type mycotoxins … biological specimens from a fatal case by LC–QTOF/MS (2018)","url":"https://pubmed.ncbi.nlm.nih.gov/30227371/","year":2018,"doi":"10.1016/j.forsciint.2018.08.043","readingStatus":"abstract_read","readingScope":"Indexiertes Abstract: Satratoxin H in Herzblut, peripherem Blut und Mageninhalt; DOI 10.1016/j.forsciint.2018.08.043.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-satratoxin-cells","title":"Roridin E and satratoxin H … induce endoplasmic reticulum stress-dependent apoptosis … (2025)","url":"https://pubmed.ncbi.nlm.nih.gov/40811904/","year":2025,"doi":null,"readingStatus":"abstract_read","readingScope":"Abstract gelesen: B16F10-Mausmelanomzellen und molekulares Docking; keine klinische Therapiestudie.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-bolesatin-isolation","title":"Purification and some properties of bolesatine … from the mushroom Boletus satanas (1989)","url":"https://pubmed.ncbi.nlm.nih.gov/2774970/","year":1989,"doi":null,"readingStatus":"metadata_checked","readingScope":"Indexierte Publikationsangaben zur Reinigung und Hemmung der Proteinsynthese in vitro.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-bolesatin-mechanism","title":"Mode of action of bolesatine … Mechanistic approaches (1995)","url":"https://pubmed.ncbi.nlm.nih.gov/7624882/","year":1995,"doi":"10.1016/0300-483X(95)03058-N","readingStatus":"abstract_read","readingScope":"Abstract vollständig gelesen: Nukleosidtriphosphat-Hydrolyse, Abgrenzung von ribosomeninaktivierenden Proteinen; DOI 10.1016/0300-483X(95)03058-N.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-acromelic-analysis","title":"Rapid LC-MS Determination of Acromelic Acids A and B … (2017)","url":"https://www.jstage.jst.go.jp/article/shokueishi/58/5/58_241/_article/-char/en","year":2017,"doi":"10.3358/shokueishi.58.241","readingStatus":"abstract_read","readingScope":"Abstract gelesen: Nachweis beider Stoffe in Pilzresten eines Vergiftungsfalls; DOI 10.3358/shokueishi.58.241.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-pleuro-existence","title":"Proof of the existence of an unstable amino acid: pleurocybellaziridine in Pleurocybella porrigens (2011)","url":"https://pubmed.ncbi.nlm.nih.gov/21268219/","year":2011,"doi":"10.1002/anie.201004646","readingStatus":"metadata_checked","readingScope":"Bibliografischer Originalnachweis; kein Abstract verfügbar. Experimentelle Einordnung anhand der ergänzend genannten Originalarbeit von 2023; DOI 10.1002/anie.201004646.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx220-pleuro-model","title":"Possible molecular mechanism for acute encephalopathy by angel-wing mushroom ingestion – Involvement of three constituents in onset (2023)","url":"https://doi.org/10.1016/j.toxicon.2022.106958","year":2023,"doi":"10.1016/j.toxicon.2022.106958","readingStatus":"abstract_read","readingScope":"Autorenabstract über University of Fukui gelesen: Kombination von Pleurocybellin, Lektin und Pleurocybellaziridin im injizierten Mausmodell; menschliche Kausalität nicht abschließend bewiesen.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-schulzova-2009","title":"Agaritine content of 53 Agaricus species collected from nature","url":"https://doi.org/10.1080/02652030802039903","year":2009,"doi":"10.1080/02652030802039903","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen; Food Addit. Contam. A 26:82–93. Keine Auswertung der vollständigen artweisen Ergebnistabelle; daraus keine pauschale Stoffzuordnung zu allen Champignonporträts.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-friederich-1986","title":"The mutagenic activity of agaritine and its derivatives detected with the Ames test","url":"https://doi.org/10.1007/BF01041921","year":1986,"doi":"10.1007/BF01041921","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen, PMID 2876563: gereinigtes Agaritin und Derivate, Salmonella-Test mit unterschiedlichen Aktivierungsbedingungen.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-pool-zobel-1990","title":"Mutagenic and genotoxic activities of extracts derived from the cooked and raw edible mushroom Agaricus bisporus","url":"https://doi.org/10.1007/BF01612997","year":1990,"doi":"10.1007/BF01612997","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen, PMID 2229137: Pilzextrakte, Histidin-Artefakt, Säugerzell- und In-vivo-Endpunkte. Kein Versuch mit ausschließlich reinem Agaritin.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-shephard-1995","title":"Genotoxicity of agaritine in the lacI transgenic mouse mutation assay","url":"https://doi.org/10.1016/0278-6915(94)00142-B","year":1995,"doi":"10.1016/0278-6915(94)00142-B","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen; Food Chem. Toxicol. 33:257–264. 15 Wochen; Pilzdiäten und ein Extrakt mit 30 % Agaritin. Die modellierte menschliche Krebsrisikozahl wird nicht als Beobachtungsbefund übernommen.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-walton-2001","title":"The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinase","url":"https://doi.org/10.1016/S0300-483X(00)00430-3","year":2001,"doi":"10.1016/S0300-483X(00)00430-3","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen, PMID 11297805: Homogenate, Enzyme und bakterielle Mutagenität; mindestens drei Metaboliten, dabei kein Nachweis des erwarteten freien HMPH im Homogenatversuch.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-kondo-2008","title":"The metabolisms of agaritine, a mushroom hydrazine in mice","url":"https://doi.org/10.1016/j.fct.2007.10.022","year":2008,"doi":"10.1016/j.fct.2007.10.022","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen, PMID 18061328; Food Chem. Toxicol. 46:854–862. LC-MS/MS, oraler Mausversuch, Urinmarker 8-OHdG; kein klinischer Krebsendpunkt.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-toth-1981","title":"Attempted tumor induction with agaritine in mice","url":"https://pubmed.ncbi.nlm.nih.gov/7201775/","year":1981,"doi":null,"readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC gelesen: lebenslange Trinkwasserexposition von Swiss-Mäusen; unter diesen Bedingungen kein nachweisbarer kanzerogener Effekt. Berichtete Krampfanfälle schließen eine pauschale Aussage „wirkungslos“ aus.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-iarc-1983","title":"Agaritine · IARC Monographs, Volume 31","url":"https://www.inchem.org/documents/iarc/vol31/agaritine.html","year":null,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Historische Zusammenfassung und Bewertung vollständig gelesen, Abschnitte 5.1–5.3. Supplement 7: Gruppe 3. Diese zeitgebundene Bewertung wird weder als neue Bewertung noch als Unbedenklichkeitsbeleg dargestellt.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-schulzova-2002","title":"Influence of storage and household processing on the agaritine content of the cultivated Agaricus mushroom","url":"https://web.vscht.cz/~hajslovj/publications/schuzlova_agaritine_fac_vol19_p853-862.pdf","year":2002,"doi":"10.1080/02652030210156340","readingStatus":"selected_sections_read","readingScope":"Volltext, gedruckte S. 853–862: Methoden, Ergebnisse und Diskussion gelesen. Tatsächlich untersuchte Proben: A. hortensis und A. bitorquis; Abb. 2 unterscheidet Pilz, Kochwasser und Gesamtsystem. DOI 10.1080/02652030210156340.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-libenska-2025","title":"Influence of UV-B and culinary treatment on vitamin D2 and agaritine in button mushrooms","url":"https://doi.org/10.1016/j.jfca.2024.106879","year":2025,"doi":"10.1016/j.jfca.2024.106879","readingStatus":"abstract_read","readingScope":"Vollständiges Abstract über Europe PMC/AGR und Verlagsmetadaten gelesen; J. Food Compos. Anal. 137:106879. UV-behandelte weiße Kulturchampignons; Nachweisgrenzen und vollständige Methoden nicht geprüft. Aussage zu nicht beobachteten Abbauprodukten bleibt auf diese Untersuchung beschränkt.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"agaritin-ogasawara-2023","title":"Agaritine derived from Agaricus blazei Murrill induces apoptosis via mitochondrial membrane depolarization in hematological tumor cell lines","url":"https://www.jstage.jst.go.jp/article/fmj/9/2/9_2022-021/_article","year":2023,"doi":"10.20407/fmj.2022-021","readingStatus":"selected_sections_read","readingScope":"Abstract sowie Volltextabschnitte Materials and Methods, Results, Discussion und Conclusion über Europe PMC/PMC10206889 gelesen; Fujita Med. J. 9:147–153, DOI 10.20407/fmj.2022-021. Kommerzielles Agaritin-Monohydrat, vier Tumorzelllinien, drei unabhängige Experimente; keine Behandlung von Menschen.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-bfr-faq-2024","title":"Fragen und Antworten zu Ergotalkaloiden in Getreideerzeugnissen","url":"https://www.bfr.bund.de/fragen-und-antworten/thema/fragen-und-antworten-zu-ergotalkaloiden-in-getreideerzeugnissen/","year":2024,"doi":null,"readingStatus":"page_read","readingScope":"Seite vollständig im Original-HTML gelesen, alle zehn Fragen: Vorkommen im Mutterkorn, akute und chronische Wirkungen, EFSA-Richtwerte 2012, Eintrag über Bruchstücke und Stäube, Nicht-Erkennbarkeit für Verbraucher, empfindliche Gruppen, BfR-Bewertung 2023, Höchstgehalte nach VO (EU) 2021/1399 und 2024/1808. Seitendatum 25.07.2024; auf derselben Seite steht zusätzlich der Vermerk „Aktualisierte Fassung vom 12. November 2013“. Das verlinkte PDF wurde nicht gesondert gelesen.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-bfr-2023","title":"Bewertung gesundheitlicher Risiken durch Ergotalkaloide in ausgewählten Getreideprodukten","url":"https://www.bfr.bund.de/cm/343/bewertung-gesundheitlicher-risiken-durch-ergotalkaloide-in-ausgewaehlten-getreideprodukten.pdf","year":2023,"doi":"10.17590/20230925-094324-0","readingStatus":"selected_sections_read","readingScope":"PDF (66 S., DOI 10.17590/20230925-094324-0) in Abschnitten gelesen: Zusammenfassung S. 1–2, Abschnitte 1–2 (S. 2–4), 3.1.1 Gefahrenidentifizierung (S. 4–5), 3.1.2 Gefahrencharakterisierung (S. 5–6), 3.2 (S. 38–39) sowie Nachtrag Abschnitte 4–5 (S. 40–41). Expositionstabellen und Abschnitte 3.1.3, 3.1.4 und 6 nur über die Ergebnisabschnitte. Die Bewertung bezieht sich auf die damals für den 1. Juli 2024 geplanten Absenkungen nach VO (EU) 2021/1399; VO (EU) 2024/1808 verschob einen Teil davon später.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-lgl-2024","title":"Mutterkorn und Mutterkornalkaloide in Getreide und Mehl","url":"https://www.lgl.bayern.de/lebensmittel/chemie/schimmelpilzgifte/mutterkornalkaloide/index.htm","year":2024,"doi":null,"readingStatus":"page_read","readingScope":"Seite vollständig im Original-HTML gelesen: Vorkommen und Bildung, Chemische Struktur, Gesundheitliche Beurteilung, Höchstgehaltsregelungen, Untersuchungen, Quellenliste; aktualisiert 15.10.2024. Die dort genannten JECFA-Werte von 2021 wurden nicht übernommen (JECFA-Bericht nicht gelesen); die Bezeichnungen „Familie Claviceps“ und „Schimmelpilz“ wurden nicht übernommen.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-efsa-2012","title":"Scientific Opinion on Ergot alkaloids in food and feed","url":"https://doi.org/10.2903/j.efsa.2012.2798","year":2012,"doi":"10.2903/j.efsa.2012.2798","readingStatus":"abstract_read","readingScope":"Nur Abstract gelesen (PMC-Datensatz PMC13093078 mit Abstract, Gremienangaben und Literaturliste). Der Volltext (158 S.) wurde nicht gelesen: PDF bei PMC hinter einer Bot-Prüfung, Verlagsseite HTTP 403, kein Volltext über Europe PMC; nicht umgangen. Hauptalkaloide, Referenzpunkt und Richtwerte zusätzlich in EFSA 2017 (Einleitung) und BfR 2023 (Abschnitt 3.1.2) bestätigt.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-efsa-2017","title":"Human and animal dietary exposure to ergot alkaloids","url":"https://doi.org/10.2903/j.efsa.2017.4902","year":2017,"doi":"10.2903/j.efsa.2017.4902","readingStatus":"selected_sections_read","readingScope":"Volltext über Europe PMC (PMC7010019) gelesen: Summary, Introduction mit 1.1, Abschnitte 3.1–3.1.4 (Vorkommen, Anteile der Epimere, Sklerotiendaten), Abschnitt zu Sklerotien und Alkaloidgehalten, Uncertainties, Conclusions und Recommendations. Expositionsabschnitte nur über Summary und Conclusions; Tabellen und Anhänge nicht ausgewertet.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-eu-2023-915","title":"Verordnung (EU) 2023/915 der Kommission vom 25. April 2023 über Höchstgehalte für bestimmte Kontaminanten in Lebensmitteln","url":"https://eur-lex.europa.eu/legal-content/DE/TXT/HTML/?uri=CELEX:32023R0915","year":2023,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Ursprungsfassung (ABl. L 119 vom 5.5.2023, S. 103) im EUR-Lex-HTML gelesen: Art. 8, Art. 10 Abs. 1 Buchst. b und Anhang I Nr. 1.8 (Mutterkorn-Sklerotien; Ergotalkaloide als Untergrenze der Summe aus sechs Epimerenpaaren, Ergocryptin/Ergocryptinin in α- und β-Form). Die Zahl „zwölf“ steht nicht im Verordnungstext, sondern bei BfR, LGL und EFSA. Spätere Änderungen von Nr. 1.8 über VO (EU) 2024/1808 und die konsolidierte Fassung.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-eu-2024-1808","title":"Verordnung (EU) 2024/1808 der Kommission vom 1. Juli 2024 zur Änderung der Verordnung (EU) 2023/915 in Bezug auf den Zeitpunkt, ab dem niedrigere Höchstgehalte für Mutterkorn-Sklerotien und Ergotalkaloide in Lebensmitteln gelten","url":"https://eur-lex.europa.eu/eli/reg/2024/1808/oj","year":2024,"doi":null,"readingStatus":"full_text_read","readingScope":"Volltext im EUR-Lex-HTML gelesen: Erwägungsgründe 1–8 (u. a. gestiegene Prävalenz aufgrund klimatischer Bedingungen), Art. 1–2, Anhang mit Nr. 1.8.1.2 (Roggen 0,5 g/kg, 0,2 g/kg ab 1. Juli 2025), 1.8.2.1, 1.8.2.1a und 1.8.2.3 (Roggenmahlerzeugnisse 500 µg/kg, 250 µg/kg ab 1. Juli 2028).","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-eu-2023-915-kons","title":"Verordnung (EU) 2023/915 · konsolidierte Fassung vom 19.08.2026","url":"https://eur-lex.europa.eu/legal-content/DE/TXT/HTML/?uri=CELEX:02023R0915-20260819","year":2026,"doi":null,"readingStatus":"selected_sections_read","readingScope":"Konsolidierte Fassung 02023R0915-20260819 im EUR-Lex-HTML gelesen: Änderungsliste M1–M11 und Anhang I Nr. 1.8. Nr. 1.8 ist darin nur durch M7 (VO 2024/1756, Anmerkungen zu Nr. 1.8.1) und M8 (VO 2024/1808) geändert. Konsolidierte Texte haben laut EUR-Lex keine Rechtswirkung; maßgeblich bleiben die im Amtsblatt veröffentlichten Rechtsakte.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-haarmann-2009","title":"Ergot: from witchcraft to biotechnology","url":"https://doi.org/10.1111/j.1364-3703.2009.00548.x","year":2009,"doi":"10.1111/j.1364-3703.2009.00548.x","readingStatus":"selected_sections_read","readingScope":"Volltext über PMC (PMC6640538) im HTML gelesen: Summary, Abschnitte 1.1, 1.2, 2.1, Anfang von 2.2, 2.3, 3.1 und 3.2. Historische Angaben beruhen auf Sekundärliteratur der Autoren; die Opferzahl für 944–945 weicht von Miedaner & Geiger 2015 ab und wurde nicht übernommen.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-miedaner-2015","title":"Biology, Genetics, and Management of Ergot (Claviceps spp.) in Rye, Sorghum, and Pearl Millet","url":"https://doi.org/10.3390/toxins7030659","year":2015,"doi":"10.3390/toxins7030659","readingStatus":"selected_sections_read","readingScope":"Volltext über Europe PMC (PMC4379517) gelesen: Abstract, Abschnitte 1–4, 5–5.2, 6.4 (genetische und umweltbedingte Variation der Alkaloidgehalte), 7.3 und 8. Abschnitte zu Resistenzzüchtung und Fungiziden nicht ausgewertet. Lizenz CC BY.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-kodisch-2020","title":"Covariation of Ergot Severity and Alkaloid Content Measured by HPLC and One ELISA Method in Inoculated Winter Rye across Three Isolates and Three European Countries","url":"https://doi.org/10.3390/toxins12110676","year":2020,"doi":"10.3390/toxins12110676","readingStatus":"selected_sections_read","readingScope":"Volltext über Europe PMC (PMC7692364) gelesen: Abstract, Einleitung, Ergebnisse 2.4–2.5 (Isolate, Alkaloidspektrum), Diskussion 3.1–3.4, Schlussfolgerungen und Methoden 5.1 (Herkunft der drei Inokula: Deutschland, Polen, Österreich); übrige Ergebnis- und Methodenabschnitte nicht im Detail. Künstlich inokulierter Winterroggen, 372 Proben aus drei Ländern und zwei Jahren.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-crews-2015","title":"Analysis of Ergot Alkaloids","url":"https://doi.org/10.3390/toxins7062024","year":null,"doi":"10.3390/toxins7062024","readingStatus":"selected_sections_read","readingScope":"Volltext über Europe PMC (PMC4488688) gelesen: Abschnitte 1.1–1.3 (Stoffklassen, Epimerisierung an C-8), 2 (Stabilität) und 15. Methodenteil nicht ausgewertet. Die Einordnung von Ergometrin unter die Ergopeptine in Abschnitt 1.3 wird nicht übernommen (EFSA 2017: Lysergsäure-Abkömmling); die Angaben zur Rechtslage (Stand 2015) sind überholt.","accessedAt":"2026-10-18","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"tx041-gotvaldova-2022-cinctulus","title":"Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids · Panaeolus cinctulus","url":"https://doi.org/10.3390/ijms232214068","year":2022,"doi":"10.3390/ijms232214068","readingStatus":"selected_sections_read","readingScope":"Abschnitt 2 (Einleitungsabsatz: ganze Fruchtkörper, Hut und Stiel, mg/g Trockenmasse) und Tabelle 1: Panaeolus cinctulus, 12 Fruchtkörper aus 3 Kollektionen – Psilocybin 0,114–1,578, Psilocin 0,007–0,257; Abschnitt 2.1: in älteren Studien als P. subbalteatus geführt, Literaturwerte nach Stamets stark schwankend. Nur die Angaben zu P. cinctulus für die Artzuordnung genutzt; Gehalte gelten für die untersuchten getrockneten Proben, nicht als Artkonstante.","accessedAt":"2026-10-18","catalogId":"gotvaldova-tryptamines-2022","metadataBasis":"Exact work match to research catalogue; source-specific reading scope retained.","structuredAt":"2026-10-22"},{"id":"pubchem-muscimol","title":"PubChem · Muscimol · CID 4266","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4266","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-ibotensaeure","title":"PubChem · Ibotensäure · CID 1233","url":"https://pubchem.ncbi.nlm.nih.gov/compound/1233","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-muscarin","title":"PubChem · Muscarin · CID 9308","url":"https://pubchem.ncbi.nlm.nih.gov/compound/9308","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-alpha-amanitin","title":"PubChem · α-Amanitin · CID 9543442","url":"https://pubchem.ncbi.nlm.nih.gov/compound/9543442","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-orellanin","title":"PubChem · Orellanin · CID 89579","url":"https://pubchem.ncbi.nlm.nih.gov/compound/89579","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-gyromitrin","title":"PubChem · Gyromitrin · CID 9548611","url":"https://pubchem.ncbi.nlm.nih.gov/compound/9548611","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-coprin","title":"PubChem · Coprin · CID 108079","url":"https://pubchem.ncbi.nlm.nih.gov/compound/108079","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-01","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-psilocybin","title":"PubChem · Psilocybin · CID 10624","url":"https://pubchem.ncbi.nlm.nih.gov/compound/10624","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-psilocin","title":"PubChem · Psilocin · CID 4980","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4980","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-05","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-beta-amanitin","title":"PubChem · β-Amanitin · CID 76959217","url":"https://pubchem.ncbi.nlm.nih.gov/compound/76959217","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-phalloidin","title":"PubChem · Phalloidin · CID 441542","url":"https://pubchem.ncbi.nlm.nih.gov/compound/441542","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-illudin-s","title":"PubChem · Illudin S · CID 344200","url":"https://pubchem.ncbi.nlm.nih.gov/compound/344200","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-acromelsaeure-a","title":"PubChem · Acromelsäure A · CID 108086","url":"https://pubchem.ncbi.nlm.nih.gov/compound/108086","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-ustalsaeure","title":"PubChem · Ustalsäure · CID 21680754","url":"https://pubchem.ncbi.nlm.nih.gov/compound/21680754","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-polyporsaeure","title":"PubChem · Polyporsäure · CID 11056","url":"https://pubchem.ncbi.nlm.nih.gov/compound/11056","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-cycloprop-2-encarbonsaeure","title":"PubChem · Cycloprop-2-encarbonsäure · CID 25241629","url":"https://pubchem.ncbi.nlm.nih.gov/compound/25241629","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-acromelsaeure-b","title":"PubChem · Acromelsäure B · CID 158974","url":"https://pubchem.ncbi.nlm.nih.gov/compound/158974","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-satratoxin-h","title":"PubChem · Satratoxin H · CID 6438478","url":"https://pubchem.ncbi.nlm.nih.gov/compound/6438478","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-pleurocybellaziridin","title":"PubChem · Pleurocybellaziridin · CID 53235787","url":"https://pubchem.ncbi.nlm.nih.gov/compound/53235787","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-10","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"},{"id":"pubchem-agaritin","title":"PubChem · Agaritin · CID 439517","url":"https://pubchem.ncbi.nlm.nih.gov/compound/439517","year":null,"doi":null,"readingStatus":"record_read","readingScope":"Compound-Datensatz; Summenformel, molare Masse und 2-D-Struktur über PUG REST abgerufen. Datenbankangaben belegen keine medizinische Wirksamkeit.","accessedAt":"2026-10-14","catalogId":null,"metadataBasis":"Existing source record; null means not separately established.","structuredAt":"2026-10-22"}]}